Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

Annals of surgical oncology - 1 Nov 2013

Chen Yi-Ling, Uen Yih-Huei, Li Chien-Feng, Horng Kuo-Chan, Chen Lih-Ren, Wu Wen-Ren, Tseng Hong-Yu, Huang Hsuan-Ying, Wu Li-Ching, Shiue Yow-Ling

Abstract excerpt

BACKGROUND: Through data mining the Stanford Microarray Database, the stathmin 1 (STMN1) transcript was found to be frequently upregulated in the hepatocellular carcinoma (HCC) with low alpha-fetoprotein level. The molecular mechanism of STMN1 upregulation in HCCs remained unclear. METHODS: Quant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Fetoproteins
Share to Chromatin Immunoprecipitation
Share to E2F1 Transcription Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoenzyme Techniques

Share to Luciferases

Share to RNA, Small Interfering

Share to Stathmin

Share to Transcription Factor DP1

Source

Identifiers

PMID: 22911364
DOI: 10.1245/s10434-012-2519-8

Genes

STMN1
TFDP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22911364-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.PMID 22911364Read ↗

Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian CancerSemantic proximity Read ↗

Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.Semantic proximity Read ↗

Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular CarcinomaSemantic proximity Read ↗

Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinomaSemantic proximity Read ↗

E2F8 Contributes to Human Hepatocellular Carcinoma via Regulating Cell ProliferationSemantic proximity Read ↗

UHRF1 Drives Hepatocellular Carcinoma Progression via Epigenetic Repression of SFMBT2Semantic proximity Read ↗

Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastomaSemantic proximity Read ↗

hMSH2 Coordinated with the Expression of E2F1 Promotes Platinum Response in Epithelial Ovarian CancerSemantic proximity Read ↗

Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.Semantic proximity Read ↗

E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcriptionSemantic proximity Read ↗

LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.Semantic proximity Read ↗

Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.